Johnson Johnson clears a few hurdles, but Wall Street focuses on weak guidance
Jan 22, 2025
Johnson & Johnson’s stock dropped more than 3% Wednesday after the medical-technology and drug company beat estimates for the fourth quarter but as lower sales guidance for the year stoked fears of tougher times ahead.
https://www.marketwatch.com/story/j-js-earnings-beat-estimates-but-guidance-is-mixed-af40c571?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service